in order to try to find more evidence to confirm that TGIF1 is a pathogenic molecule for the prognosis of patients with glioma, the study used a meta‐analysis to find that each data showed that TGIF1 was a risk for the prognosis of patients in seven independent datasets and the pooled HR for the association between TGIF1 expression and OS in patients was 1.61 (1.32–1.96). The gene discussed is TGIF1; the disease is glioma.